Table 2 Antimicrobial susceptibility profile* of carbapenem resistant A. baumannii complex isolates (N=232)
Antibiotic | Susceptible (µg/ml) | Intermediate (µg/ml) | Resistant (µg/ml) |
|---|---|---|---|
Ampicillin | - | - | 100.0% ( 32) |
Amoxicillin/clavulanic acid | - | - | 100.0% ( 32) |
Piperacillin/tazobactam | - | - | 100.0% ( 32) |
Cefuroxime | - | - | 100.0% ( 32) |
Cefuroxime Axetil | - | - | 100.0% ( 32) |
Cefoxitin | - | - | 100.0% ( 32) |
Cefotaxime | - | - | 100.0% ( 32) |
Nitrofurantoin | - | - | 100.0% ( 32) |
Meropenem | - | - | 100.0% ( 16) |
Imipenem | - | - | 100.0% ( 16) |
Cefepime | - | 0.4% (9 - 31) | 99.6% ( 32) |
Nalidixic acid | 8.1% ( 2) | - | 91.9% ( 32) |
Ciprofloxacin | 9.0% ( 1) | - | 91.0% ( 4) |
Trimethoprim/ Sulfamethoxazole | 12.6% ( 20) | - | 87.4% ( 320) |
Ceftazidime | 7.6% ( 8) | 12.6% (9-31) | 79.8% ( 64) |
Gentamicin | 9.4% ( 1) | 12.6% (2-15) | 78.0% ( 16) |
Amikacin | 78.0% ( 16) | 11.7% (17-63) | 10.3% ( 64) |
Tigecycline | 75.8% ( 0.25) | 16.6% (1-7) | 7.6% ( 8) |
Colistin | 100.0% ( 2) | - | - |